Are Stem Cells FDA-Approved for Spinal Cord Injury?
At a Glance
No FDA-approved stem cell treatment has been proven to cure or restore function after spinal cord injury. Current therapies remain investigational, so patients should avoid unregulated clinics, continue rehabilitation, and review legitimate clinical trials with a physiatrist.
In this answer
4 sections
No, there are currently no FDA-approved stem cell treatments to cure or restore function after a spinal cord injury (SCI). While research is actively ongoing, all stem cell therapies for SCI are considered strictly investigational [1]. The FDA has not authorized any stem cell product as a standard, proven treatment for SCI [2].
Because spinal cord injuries are devastating and life-changing, it is entirely natural to hope for a cure. However, it is critical to understand the difference between legitimate, highly regulated clinical research and unproven treatments marketed by unregulated clinics.
The Reality of Current Stem Cell Research
Stem cell therapy for SCI is an active area of scientific research. Scientists are exploring different types of cells, such as mesenchymal stem cells (adult cells often taken from bone marrow or fat), neural stem cells (cells that can become nervous system tissue), and iPSCs (genetically reprogrammed adult cells) [3][4].
Most legitimate research is currently in Phase I or Phase II clinical trials. This means the studies are primarily focused on evaluating safety, determining the correct dosage, and testing delivery methods (like injecting into the spinal fluid), rather than proving the treatment works [1][5].
Some early studies have reported changes in the ASIA Impairment Scale (AIS) (a grading tool doctors use to measure sensory and motor function) [6][3]. However, these early studies are often small and lack a control group. This makes it difficult to know if improvements were caused by the stem cells, or if they were the result of spontaneous natural recovery and intensive physical rehabilitation [6]. Furthermore, a statistical change on a grading scale does not automatically translate to a clinically meaningful improvement in daily functions, like walking, hand use, or bladder control.
The Dangers of Unproven Clinics
Because there is no approved stem cell cure, some patients seek out unregulated or deceptive clinics, often traveling to other countries in a practice known as “medical tourism.” These clinics frequently use scientific-sounding marketing to appear legitimate, but they bypass standard regulatory safety checks [7]. Paying thousands of dollars for an experimental treatment does not make it safe or effective [8].
Risks of receiving unproven stem cell treatments include:
- Medical Complications: Unregulated treatments have caused serious adverse effects, including severe infections, dangerous immune reactions (inflammation), neuropathic pain, and sometimes a worsening of neurological function [9][3].
- Abnormal Tissue Growth: Injecting unproven cells into the central nervous system (the brain and spinal cord) carries a risk of abnormal tissue growth or tumors, known as tumorigenesis [10]. This risk varies heavily depending on how the cells are manufactured and delivered.
- Financial Toxicity: Unregulated clinics charge massive out-of-pocket fees that are rarely covered by insurance, leading to devastating financial loss [11].
- Impact on Future Trials: Receiving an unregulated cell therapy may make you ineligible for some future legitimate clinical trials, as prior cell treatments or immune responses can interfere with new study protocols.
How to Evaluate Legitimate Clinical Trials
If you are considering participating in a clinical trial, it is vital to know how to identify legitimate, well-regulated research.
- Understand ClinicalTrials.gov: In the United States, trials are listed on ClinicalTrials.gov. However, simply being listed on this website does not mean the FDA has approved the study or that the treatment is proven safe or effective. It is only a registry.
- Look for FDA Oversight: Legitimate U.S. trials studying new cell therapies must operate under an active Investigational New Drug (IND) application [5]. An IND means the FDA allows the study to proceed, but it does not mean the FDA endorses the treatment as safe or effective.
- Understand the Costs: Legitimate clinical trials generally do not charge you for the experimental product itself. However, you may still be responsible for travel, lodging, routine medical care, or insurance co-pays. If a clinic asks you to pay a large upfront fee specifically for the “stem cells,” it is a major red flag [11].
What You Can Do Now
Never delay or stop your standard SCI medical care or rehabilitation in hopes of finding an experimental cure. Ongoing, evidence-based rehabilitation is proven to help maximize your independence, manage pain and spasticity, and prevent complications like skin breakdown or urinary tract infections. Work closely with your physiatrist (a doctor specializing in physical medicine and rehabilitation) to build a care plan that supports your best possible quality of life today.
Common questions in this guide
Are any stem cell treatments FDA-approved for spinal cord injury?
Can a clinical trial listed on ClinicalTrials.gov be trusted as FDA-approved?
What can happen if I receive stem cells from an unregulated clinic?
How can I tell whether a spinal cord injury stem cell trial is legitimate?
Can stem cell therapy restore movement after spinal cord injury?
Should I continue rehabilitation while considering an experimental treatment?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.If I am interested in a specific clinical trial, can you help me review the informed consent document to understand the true risks and realistic goals?
- 2.What specific functional improvements should I realistically expect from my current rehabilitation plan versus what an experimental therapy might claim?
- 3.How long has it been since my injury, and how does my current ASIA (AIS) grade affect my eligibility for legitimate clinical research?
- 4.How would participating in a clinical trial impact my current standard of care and daily rehabilitation routine?
- 5.If I undergo an experimental treatment and experience complications, who will manage and pay for that medical care?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (11)
- 1
Disease-specific interventions using cell therapies for spinal cord disease/injury.
Zipser CM, Curt A
Handbook of clinical neurology 2024; (205()):263-282 doi:10.1016/B978-0-323-90120-8.00007-1.
PMID: 39341658 - 2
Stem cell therapy for spinal cord injury: lessons from Japan's experiment in regulatory deregulation.
Kawaguchi H
The spine journal : official journal of the North American Spine Society 2026; (26(7)):1239-1242 doi:10.1016/j.spinee.2026.01.005.
PMID: 41512928 - 3
Current status and future perspectives on stem cell transplantation for spinal cord injury.
Agosti E, Zeppieri M, Pagnoni A, et al.
World journal of transplantation 2024; (14(1)):89674 doi:10.5500/wjt.v14.i1.89674.
PMID: 38576751 - 4
Regenerative Medicine Strategies for Spinal Cord Injury: Advances in Stem Cell Therapy.
Anwar AI, Abd-Elsayed A, Kaye AD
Brain sciences 2026; (16(5)) doi:10.3390/brainsci16050461.
PMID: 42192774 - 5
Safety and early efficacy of iPSC-derived motor neuron progenitor cells in subacute spinal cord injury: protocol for a phase I, multicentre, open-label, single-arm trial.
Pang M, Kang J, Yang Y, et al.
BMJ open 2026; (16(7)):e111718 doi:10.1136/bmjopen-2025-111718.
PMID: 42419896 - 6
Mesenchymal Stem Cell Therapy in Traumatic Spinal Cord Injury: A Systematic Review.
Montoto-Meijide R, Meijide-Faílde R, Díaz-Prado SM, Montoto-Marqués A
International journal of molecular sciences 2023; (24(14)) doi:10.3390/ijms241411719.
PMID: 37511478 - 7
Selling stem cell 'treatments' as research: prospective customer perspectives from crowdfunding campaigns.
Snyder J, Turner L
Regenerative medicine 2018; (13(4)):375-384 doi:10.2217/rme-2018-0007.
PMID: 29985757 - 8
Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions.
Bauer G, Elsallab M, Abou-El-Enein M
Stem cells translational medicine 2018; (7(9)):676-685 doi:10.1002/sctm.17-0282.
PMID: 30063299 - 9
International stem cell tourism: a critical literature review and evidence-based recommendations.
Lyons S, Salgaonkar S, Flaherty GT
International health 2022; (14(2)):132-141 doi:10.1093/inthealth/ihab050.
PMID: 34415026 - 10
Clinical translation of stem cell therapy for spinal cord injury still premature: results from a single-arm meta-analysis based on 62 clinical trials.
Shang Z, Wang M, Zhang B, et al.
BMC medicine 2022; (20(1)):284 doi:10.1186/s12916-022-02482-2.
PMID: 36058903 - 11
Academic physician specialists' views toward the unproven stem cell intervention industry: areas of common ground and divergence.
Smith C, Crowley A, Munsie M, et al.
Cytotherapy 2021; (23(4)):348-356 doi:10.1016/j.jcyt.2020.12.011.
PMID: 33563545
This page explains the FDA status and risks of investigational stem cell treatments for spinal cord injury for informational purposes only and does not constitute medical advice. Discuss clinical trials, rehabilitation, and treatment decisions with your physiatrist or another qualified healthcare professional.
Get notified when new evidence is published on Spinal cord injury.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.